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Abstract: Atypical fi broxanthoma is an uncommon mesenchymal tumor that manifests clinically as a reddish 
papule or nodule in sun-exposed areas of the body. The clinical presentation is not specifi c and histology and 
immunohistochemistry are both necessary for a correct diagnosis. Surgery is the gold standard of therapy. Re-
currence and metastasis should be excluded with a follow-up at 6 months, since this tumor should nowadays be 
considered a medium-grade neoplasm, rather than low-grade as previously believed. We report the case of two 
friends who came to our hospital during the same period, complaining of very similar lesions. After biopsy and 
immunohistochemical examination, a diagnosis of atypical fi broxanthoma in both cases was formulated.
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 INTRODUCTION
AFX, also termed pseudosarcoma, 
paradoxical fi brosarcoma or pseudosarcomatous 
reticulohistiocytoma, is an uncommon superfi cial 
fi brohistiocytic tumor. It occurs mainly on sun-
exposed skin of elderly individuals and shows a male 
predominance. The lesion usually presents as an 
asymptomatic, solitary, often dome-shaped nodule, 
which may be ulcerated. Histologically, AFX consists 
of an admixture of highly pleomorphic spindle, 
epithelioid and multinucleated giant cells in the 
dermis. 1 The growth pattern of AFX has a propensity 
of local invasion beyond the involved skin, thereby 
presenting the risk of local recurrence after surgical 
excision, which is the gold standard of treatment. 2
CASE REPORT
A 78-year-old healthy man was referred to our 
clinic due to the presence of a juicy-red, dome-shaped 
nodule. The nodule, 1cm in diameter, appeared on 
the left antihelix appeared approximately one year 
before (Figure 1). Physical examination revealed sun-
damaged skin and a surgical scar due to previous 
excision of a basal cell carcinoma.
One week later, a friend of his (a 75-year-old 
man) came to our department with a similar skin 
lesion. The nodule was oval-shaped, exophytic and 
bleeding (Figure 2). It was located on the right helix 
and had a diameter of 1.5cm. According to the patient, 
the lesion appeared about 2 months beforehand and 
had been increasing in size.
In both patients, we performed surgical removal of 
the lesions, suspecting basal cell carcinomas. Histological 
examination showed similar fi ndings in both samples 
such as central erosion associated with pleomorphic 
spindle and epithelioid cell infi ltration in the context 
of a thickened vascularized stroma (Figure 3 and 4). 
The proliferating cells were CD68+ (Figure 5), CD163+, 
FXIII+ and smooth muscle actin+, while melanocytic 
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markers (S100, melan-A, HMB45) were negative and 
melanoma was therefore excluded. A fi nal diagnosis of 
atypical fi broxanthoma (AFX) was made in both cases, 
which was subsequently treated via surgical excision. 
The 6-month follow-up did not reveal any new lesions 
in our patients.
DISCUSSION
AFX is a rare, rapidly growing neoplasm of 
intermediate malignant potential.
First described by Helwig3 in 1961 as a low-
grade dermal tumor with atypical spindle cells, AFX is 
now generally considered an intermediate malignant 
potential tumor with a low metastasize-grade2. The 
tumor usually presents as a pink or red papule/nodule, 
associated or not with erythema and desquamation. 
Ulceration and bleeding may be present. The tumor is 
usually skin-colored or brown-red, painless, fi rm and 
frequently ulcerated4. Lesions are smaller than 2cm 
in diameter, although the range may vary between 
0.3-10 cm. No characteristic dermatoscopic features 
have been described. Since clinical presentation is not 
specifi c, histopathologic examination is essential for 
diagnosis.
AFX is typically asymptomatic, unilesional and 
localized in sun-exposed areas (nose, ears and lips) of 
elderly patients with a higher incidence in the seventh 
and eighth decade of life4.
The pathogenesis is commonly related to 
ultraviolet exposure. Several studies have assessed 
a link to p53 protein and demonstrated signature 
mutations in the p53 gene, occurring from UV 
radiation5. Moreover x-ray exposure also seems to 
induce AFX development. A study conducted on 
140 AFX cases revealed that 4.2% of lesions had been 
developing on previous radiation sites1.
FIGURE 1: A reddish nodule on the left antihelix 
(fi rst patient)
FIGURE 3: An erosed nodule composed of pleomorphic 
cells (H.E. – 4x)
FIGURE 2: An exophytic nodule on the right helix 
(second patient)
FIGURE 4: Close-up view of Figure 3 (H.E. – 20x)
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In comparison with typical fi broxanthoma, 
AFX usually occurs in older individuals (mean age 
69) with sun-damaged or radiation-damaged skin 
on the head, neck or scalp. Men are distinctly more 
affected, representing between 2/3 and 3/4 of cases6. 
Differential diagnoses include dermatofi brosarcoma 
protuberans, spindle cell squamous carcinoma and 
spindle cell malignant melanoma2.
 Histopathologic examination characteristically 
reveals a well-circumscribed, exophytic, uncapsulated 
tumor located in the dermis. No extension to 
subcutaneous fat is usually observed. The tumor 
consists of many atypical spindle and epithelioid cells 
with pleomorphic vesicular or hyperchromatic nuclei. 
Atypical multinucleated giant cells and mitoses are 
often seen. Histological characteristics associated 
with aggressive behavior include involvement of 
larger portions of subcutis or deep soft tissues, 
vascular or perineural invasion and the presence of 
necrosis. The main histological differential diagnoses 
include spindle cell squamous carcinoma, melanoma 
and undifferentiated pleomorphic sarcoma. The 
histological diagnosis of AFX is an exclusion diagnosis. 
Immunohistochemistry is fundamental to properly 
diagnose AFX. CD68 and smooth muscle actin are 
highly positive, while HMB45 and S100 protein are 
negative4.
AFX tumors usually have a benign clinical 
course. Surgical excision is the therapy of choice. Wide 
excision with safety margins (1-2cm) is recommended 
as a fi rst choice treatment5. In the rare metastatic cases, 
treatment is patient individualized.
Recurrence and metastasis occur rarely in 
incompletely excised tumors or when the subcutis 
or deeper structures are involved and/or tumor 
necrosis or perineural-vascular invasion is present. 
Since recurrences usually appear within months to 
3 years after primary excision, a clinical follow-up 
should be performed every 3–6 months over a 2-3-year 
period. Inspection and palpation of skin, lymph nodes 
and loco-regional skin, in addition to lymph node 
sonography, are crucial studies2. ❑
FIGURE 5: Proliferating cells are CD68-positive 
CD68 – 20x)
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